The specific type of lymphoma and the IPI score are the major factors currently used in treatment decisions. On the basis of factors identified in multivariate analysis of the above data set, the International Prognostic Index was proposed. Five pretreatment characteristics were found to be ...
In conclusion, it is evident that histological subtype and IPI-score have a strong prognostic impact on OS in pts with T-cell NHL. Thus, the distribution of risk factors in patients with T-cell NHL may be more important for OS than T-cell histology per se.doi:10.1080/10428190290016926...
The specific type of lymphoma and the IPI score are the major factors currently used in treatment decisions. On the basis of factors identified in multivariate analysis of the above data set, the International Prognostic Index was proposed. Five pretreatment characteristics were found to be ...
cd79 on b lymphoid cells and cd45 on t lymphoid cells, the extension studies concluding that the mediastinal metastases were: non-hodgkin锛焥 lymphoma immunophenotyping b extranodal cd20 + stage iv renal with metastases in the superior mediastinum ipi score may/2009 classified how secondary to high...
9 The PPV was 56% in patients with an IPI score <3, compared with 80% in patients with an IPI ≥3. Avivi et al reported outcomes for 119 patients with DLBCL who underwent PET/CT surveillance.12 In a subset of patients who receive R-CHOP, the PPV was 23%, with a false-positive ...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the disease, performance status of the patient, and histologic subtypes. Treatment of localized and advanced disease varies considerably. Below is a general treatment algorithm for DLBCL...
favorable impact of rituximab, likelihood of cure is approximately 90% for an IPI score of 0, 80% for a score of 1 or 2 and 55% for a score of 3–5.18 The corresponding outcomes for the PTCLs are about 1/2 of those for otherwise matched B-cell lymphoma.19,20 Important exceptions....
Primary breast lymphoma is an uncommon disease with poor clinical outcome. Breast lymphomas present less than 0.5% of malignant breast neoplasms and 2.2% of extranodal lymphomas. This study investigated the clinicopathological features and optimal treatm
Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project BACKGROUND: Peripheral T-cell lymphoma (PTCL) is rare in most parts of the world. Therefore, we have evaluated the 96 cases of PTCL diagnosed within the No... ...
Hodgkin lymphoma (HL) represents a neoplasm primarily affecting adolescents and young adults, necessitating the development of precise diagnostic and monitoring tools. Specifically, classical Hodgkin lymphoma (cHL), comprising 90% of cases, necessitating tailored treatments to minimize late toxicities. Althou...